Micellar electrokinetic chromatography method development for determination of impurities in Ritonavir

Journal of Pharmaceutical and Biomedical Analysis

Volumn 53, Issue 5, 2010, Pages 1210-1216

  Carvalho, Alexandre Zatkovskis ^a   El Attug, Mohamed Nouri ^a   Zayed, Sahar Ebrahem ^a   Hove, Els Van ^a   Duppen, Joost Van ^a   Hoogmartens, Jos ^a   Schepdael, Ann Van ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Capillary electrophoresis; Mass spectrometry; MEKC; Quality control; Ritonavir related substances

Indexed keywords

2 ISOPROPYL 4 (METHYLAMINOMETHYL)THIAZOLE CARBONYLVALINE; 5 HYDROXYMETHYLTHIAZOLE; ACETONITRILE; BORATE SODIUM; CARBONIC ACID; DODECYL SULFATE SODIUM; ELECTROLYTE; RITONAVIR; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VALINE;

ARTICLE; CARBONATED BEVERAGE; DRUG ANALYSIS; DRUG DETERMINATION; DRUG IMPURITY; DRUG SOLUBILITY; MASS SPECTROMETRY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PH; PRIORITY JOURNAL; QUALITY CONTROL;

CHROMATOGRAPHY, MICELLAR ELECTROKINETIC CAPILLARY; DRUG CONTAMINATION; HIV PROTEASE INHIBITORS; MICELLES; RITONAVIR;

EID: 77955922538     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.07.022     Document Type: Article

References (23)

1. (accessed 07.01.10). http://www.fda.gov/oashi/aids/virals.html.
2. Corbett A.H., Lim M.L., Kashuba A.D. Kaletra (Lopinavir/Ritonavir). Ann. Pharmacother. 2002, 36:1193-1203.
3. Ritonavir Monograph, Indian Pharmacopoeia, Addendum 2002, Ministry of Health and Family Welfare, Delhi, India, pp. 925-926.
4. Ritonavir Monograph International Pharmacopoeia 2006, World Health Organization (WHO), Geneva, Switzerland, pp. 837-840. 4th ed.
5. Ritonavir Monograph United States Pharmacopeia 2008, United States Pharmacopeia Convention, Rockville, MD, USA, pp. 3520-3522. 32nd ed.
6. Ritonavir Monograph European Pharmacopoeia 2008, European Directorate for the Quality of Medicines, Strasbourg, France, pp. 2832-2835.
7. Gutleben W., Scherer K., Tuan N.D., Stoiber H., Dierich M.P., Zemann A. Simultaneous separation of 11 protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by co-electroosmotic capillary zone electrophoresis. J. Chromatogr. A 2002, 982:153-161.
8. Gutleben W., Scherer K., Tuan N.D., Stoiber H., Dierich M.P., Sarcletti M., Zemann A. Capillary electrophoretic separation of protease inhibitors used in human immunodeficiency virus therapy. J. Chromatogr. A 2001, 922:313-320.
9. Tuan N.D., Gutleben W., Scherer K., Stoiber H., Falkensammer B., Dierich M.P., Zemann A. Simultaneous separation of fifteen approved protease and reverse transcriptase inhibitors for human immunodeficiency virus therapy by capillary electrophoresis. Electrophoresis 2003, 24:662-670.
10. Fan B., Stewart J.T. Determination of Lamivudine/Didanosine/Saquinavir in human serum using capillary zone electrophoresis. J. Liq. Chromatogr. Rel. Technol. 2002, 25:241-249.
11. Chelyapov N., Jacobs S.A., Magee T.J. Determination of human immunodeficiency virus-1 protease inhibitors in patient serum using free solution capillary zone electrophoresis. J. Chromatogr. A 1999, 853:431-437.
12. Pereira E.A., Micke G.A., Tavares M.F.M. Determination of antiretroviral agents in human serum by capillary electrophoresis. J. Chromatogr. A 2005, 1091:169-176.
13. Hommerson P., Khan A.M., Bristow T., Harrison M.W., de Jong G.J., Somsen G.W. Drug impurity profiling by capillary electrophoresis/mass spectrometry using various ionization techniques. Rapid Commun. Mass Spectrom. 2009, 23:2878-2884.
14. Mallampati S., Pauwels J., Hoogmartens J., Van Schepdael A. CE in impurity profiling of drugs. Sep. Sci. Technol. 2008, 259-315.
15. Altria K., Marsh A., Sanger-van de Griend C. Capillary electrophoresis for the analysis of small-molecule pharmaceuticals. Electrophoresis 2006, 27:2263-2282.
16. Hilhorst M.J., Somsen G.W., de Jong G.J. Capillary electrokinetic separation techniques for profiling of drugs and related products. Electrophoresis 2001, 22:2542-2564.
17. Jouyban A., Kenndler E. Impurity analysis of pharmaceuticals using capillary electromigration methods. Electrophoresis 2008, 29:3531-3551.
18. Benedetti F., Norbedo S. Epoxyalcohol route to hydroxyethylene dipeptide isosteres: a new synthesis of the diaminoalcohol core of HIV-protease inhibitor ABT-538 (Ritonavir). Chem. Commun. 2001, 2:203-204.
19. Sham H.L., Zhao C., Li L., Betebenner D.A., Saldivar A., Vasavanonda S., Kempf D.J., Plattner J.J., Norbeck D.W. Novel Lopinavir analogues incorporating non-aromatic P-1 side chains - synthesis and structure-activity relationships. Bioorg. Med. Chem. Lett. 2002, 12:3101-3103.
20. Pinheiro E.L., Anunes O.A.C., Fortunak J.M.D. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nation. Antiviral Res. 2008, 79:143-165.
21. Gimenez F., Fernandez C., Mabondzo A. Transport of HIV protease inhibitors through the blood-brain barrier and interactions with the efflux proteins, P-glycoprotein and multidrug resistance proteins. J. Acquir. Immune Defic. Syndr. 2004, 36:649-658.
22. Terabe S. Capillary separation: micellar electrokinetic chromatography. Annu. Rev. Anal. Chem. 2009, 2:99-120.
23. Silva M. Micellar electrokinetic chromatography: methodological and instrumental advances focused on practical aspects. Electrophoresis 2009, 30:50-64.